Christa Pike was lying on an execution gurney when the first sign appeared that something was badly wrong.

Her arm hurt.

Then it burned.

Then, according to accounts from witnesses and her attorneys, she said it felt as though it might burst open.

The drug flowing through the IV tubing was pentobarbital.

Tennessee intended it to kill her.

Pike had been convicted in the 1995 murder of nineteen-year-old Colleen Slemmer and sentenced to death the following year.

On September 30, 2026, after decades of appeals, Tennessee finally attempted to carry out that sentence.

The state used its single-drug lethal-injection protocol.

Pentobarbital was administered.

Pike remained alive.

So officials used the backup administration authorized by the protocol.

She still remained alive.

Witnesses could hear her breathing.

Then came loud respiratory sounds repeatedly described as snoring.

The curtains covering the death chamber closed.

Eventually the microphone went silent.

And instead of being taken to a morgue, Pike was taken from Riverbend Maximum Security Institution in an ambulance.

That single sequence has created a question that sounds medically impossible.

How can someone survive something called a lethal injection?

The answer begins with a misunderstanding hidden inside the phrase itself.

“Lethal injection” is not a drug.

It is a procedure.

And procedures can fail.

Pentobarbital itself is a powerful barbiturate that depresses the central nervous system.

In medical use, related effects include sedation and anesthesia.

At sufficiently high systemic levels, the drug can suppress the brain structures controlling breathing.

Respiration slows.

Consciousness disappears.

At extreme exposure, breathing can stop and cardiovascular collapse can follow.

That is the physiological logic Tennessee’s execution protocol depends upon.

But for that sequence to happen as planned, the drug must actually reach the circulation.

That seemingly obvious requirement is now at the center of the Christa Pike investigation.

Dr. Joel Zivot, an anesthesiologist and Emory University professor retained by Pike’s lawyers, told ABC News that the details reported from the execution sounded to him like the IV was no longer properly inside a vein—or perhaps had never been positioned correctly in the first place.

His clue was Pike’s own reaction.

Burning.

Severe arm pain.

The sensation that the arm might burst.

Zivot said those symptoms were consistent with the chemical infiltrating the skin and soft tissue rather than flowing efficiently through the bloodstream.

If that happened, only a fraction of the intended drug might have entered Pike’s circulation quickly enough to produce the expected result.

Another anesthesiologist, Dr. Paul Allen of the University of Tennessee Health Science Center, independently pointed toward the same basic possibility after reviewing the publicly reported details.

His assessment was that the needle may not have remained properly inside the vein.

That does not yet make IV infiltration the official explanation.

The state investigation is still underway.

But the evidence that emerged after Pike reached the hospital made the theory much harder to ignore.

Her lawyers reported that both arms were swollen.

Burned.

Blistered.

Their emergency filing alleged that pentobarbital had entered tissue under the skin because the IV lines were improperly positioned or the veins had failed.

The filing says members of the execution team apparently did not recognize what was happening while the drug was being administered.

This phenomenon has a medical name.

Infiltration occurs when an IV fluid meant for the vein escapes into surrounding tissue.

Extravasation is often used when a medication capable of damaging tissue does the same thing.

The result can be swelling, pain and local injury.

And it produces an enormous difference in pharmacology.

A drug injected into a functioning vein reaches the circulation rapidly.

A drug deposited into tissue may be absorbed far more slowly and unpredictably.

So when people say Pike “survived two lethal doses,” an important qualification is necessary.

The state apparently administered the amounts called for by its execution protocol.

That does not necessarily mean Pike’s bloodstream received those full amounts in the intended manner.

If much of the drug went into her arms rather than directly into her circulation, the dose pushed through the tubing and the dose effectively delivered to the central nervous system could be very different things.

That is one possible explanation for the apparent contradiction.

The execution team administered enough drug that death should have followed under the protocol.

But the body may never have received it in the way the protocol assumed.

Pike’s lawyers say they warned Tennessee about this risk before September 30.

They cited her small veins.

They also cited thrombocytosis, a blood disorder involving elevated platelet counts, along with a history of difficulty establishing intravenous access.

During preparation for the execution, the difficulty became obvious.

According to the court filing, the execution team used at least seven needles.

At one point Pike herself reportedly suggested where personnel might have a better chance of finding access.

One removed needle was described as bent at approximately ninety degrees.

Those details matter because placing an IV is not always as simple as it appears on television.

Veins can be small.

Fragile.

Scarred.

Deep.

They can collapse.

A catheter may initially enter the vessel and later move out of position.

A line can appear to be functioning while fluid is actually accumulating in surrounding tissue.

In ordinary clinical care, staff monitor an IV site for exactly those problems.

If an infusion produces swelling, burning or significant pain, the line can be stopped and reassessed.

The unusual problem inside an execution chamber is the purpose of the procedure.

In a hospital, the medical team’s goal is to prevent injury and preserve life.

Inside an execution chamber, the state is deliberately administering a massive drug exposure intended to end it.

That tension is one reason major medical organizations, including the American Medical Association, regard physician participation in executions as ethically impermissible.

ABC News noted that the exclusion of ordinary medical practice from executions has long raised concerns about who performs technical procedures such as vascular access.

Tennessee insists its personnel followed the state’s approved protocol.

Its official statement after Pike’s failed execution said every authorized step had been completed and that the protocol contained no additional procedure once those steps had been exhausted.

That produced one of the strangest moments in modern American capital punishment.

The government had reached the end of an execution protocol.

The prisoner was still alive.

There was literally no next authorized step.

So the same state that had spent the evening trying to kill Pike suddenly had to transfer her for emergency medical treatment.

The case also exposes another misconception.

Calling a dose “lethal” does not mean death is guaranteed under every possible circumstance.

Toxicology does not work like a light switch.

The biological effect of a drug depends on how much actually reaches the body’s circulation, how rapidly it arrives, where it is delivered, the person’s physiology and what happens to the drug afterward.

That does not mean pentobarbital is unreliable as a depressant.

It means delivery matters.

Consider an extreme comparison.

A large amount of medication sitting inside an IV bag outside the body does nothing.

The same drug pushed into soft tissue behaves differently from medication delivered directly into circulation.

And even successful venous delivery depends upon the line remaining functional throughout administration.

That is why a failed IV can defeat the assumptions built into a lethal-injection protocol.

There are other possibilities investigators cannot yet rule out.

Drug concentration.

Preparation.

Storage.

Timing.

Potency.

The source of the medication.

The handling of the drug on the day of the execution.

None has yet been established as the cause of Pike’s survival.

The secrecy surrounding execution-drug supply chains has nevertheless become part of the wider debate.

The Wall Street Journal reported after Pike’s case that pharmaceutical manufacturers’ refusal to provide drugs for executions has pushed states toward increasingly opaque supply arrangements, raising questions about consistency and oversight.

Again, that does not prove Tennessee’s pentobarbital was defective.

It means the independent review must examine more than the needle placement.

The entire chain matters.

What drug was obtained?

Where did it come from?

How was it tested?

When was it prepared?

How was it stored?

Who handled it?

Was the correct concentration present?

Did the IV lines actually deliver it into the bloodstream?

Pike’s lawyers moved rapidly to ensure those questions could still be answered.

They asked a Tennessee court to order preservation of physical and electronic evidence from the execution.

That evidence could include needles, IV equipment, execution records, drug records and internal communications.

The request is significant because the case is no longer merely about whether Tennessee intended to execute Pike properly.

It is about reconstructing what physically happened inside her body.

And there is one more reason that reconstruction matters.

Pike survived long enough to reach a hospital.

That changes the scientific possibilities.

Completed executions leave witnesses, execution logs and autopsies.

The condemned person cannot describe what happened.

Pike potentially can—if she recovers sufficiently.

As of the latest confirmed reports available on October 4, however, she had not publicly been reported awake.

Her lawyers said she remained critically ill, unconscious, intubated and mechanically ventilated while hospital personnel treated the effects of the pentobarbital and the injuries to her arms.

There have been warnings that oxygen deprivation or other complications could leave lasting injury.

There has also been expert discussion that substantial recovery could still be possible.

But no reliable public medical prognosis currently establishes whether Pike will recover fully, partially, or at all.

That uncertainty should remain uncertainty.

Her survival of the execution does not mean she survived without damage.

In fact, the delayed danger helps explain another way a supposedly “failed” lethal dose can remain medically serious.

If pentobarbital accumulates outside a vein and is then absorbed gradually, the person may avoid the immediate blood concentration intended to cause rapid death but still absorb enough drug over time to cause profound sedation and respiratory suppression.

So “the execution failed” does not mean “the drug had no effect.”

Pike’s ventilator makes that obvious.

The state failed to achieve the intended immediate death.

The medication still left her critically ill.

That distinction is crucial to understanding why lethal injection is not as mechanically predictable as its name implies.

The procedure combines pharmacology with vascular access.

And vascular access is a human technical procedure.

If that step fails, everything after it becomes uncertain.

This was not the first warning Tennessee received in 2026.

Only months before Pike’s execution, the state attempted to execute Tony Carruthers.

Officials abandoned that procedure after being unable to establish adequate IV access.

No lethal drug was administered in his case.

The Carruthers failure should have made vascular access an especially obvious concern before Pike was brought into the chamber.

The overlap became even more controversial after reporting identified Dr. Mark Fowler as having been involved in both execution attempts.

Reports say Fowler oversaw aspects of Pike’s procedure after participating in the unsuccessful Carruthers attempt.

The independent review will now have to ask what Tennessee learned from Carruthers.

And whether any of those lessons were actually incorporated before Pike.

The consequences have already reached the top of the prison system.

Governor Bill Lee suspended Tennessee’s remaining executions for the rest of 2026.

He ordered a comprehensive outside review.

Tennessee Attorney General Jonathan Skrmetti said the state needs to know what happened.

Then Correction Commissioner Frank Strada announced his resignation.

Strada said he believed department personnel had followed protocol but that leaving was in the public interest while the review proceeded.

On October 3, the governor’s office announced that former U.S. Attorney Ed Stanton would conduct the independent examination of the Department of Correction’s actions during Pike’s failed execution.

That investigation now faces two fundamentally different possibilities.

The first is execution-team failure.

Perhaps the written protocol could have worked, but personnel failed to establish or maintain proper vascular access.

The second is protocol failure.

Perhaps officials followed the rules as written—and the rules themselves were not adequate to detect and respond to the problem unfolding on the gurney.

That second possibility may be even more damaging for Tennessee.

The Department of Correction’s own statement said the protocol had been followed.

If investigators confirm that claim, then Tennessee will have to explain how following its protocol produced a prisoner with two chemically injured arms who remained alive after both authorized drug administrations.

The problem would no longer be merely:

Someone made a mistake.

It would become:

The system did not know what to do when a predictable medical complication occurred.

And that leads to the larger answer to the title.

Why isn’t lethal injection always lethal?

Because execution by injection is not merely a question of whether a powerful drug exists.

It requires the state to reliably perform a medical-style procedure under conditions ordinary medicine was never designed for.

The correct chemical has to be obtained.

Properly prepared.

Stored correctly.

Delivered at the intended concentration.

Placed into a functioning vascular route.

Kept inside that route.

And administered in a way that produces the systemic exposure assumed by the protocol.

Failure anywhere along that chain can change the result.

Sometimes execution personnel cannot establish the IV at all.

That happened with Tony Carruthers.

Sometimes an IV may infiltrate.

That is one leading theory in Pike’s case.

Sometimes questions arise about drug sourcing and potency.

Other lethal-injection cases have generated those disputes.

And even when the drug reaches circulation successfully, medical experts continue debating what prisoners may experience before consciousness disappears, including questions involving pulmonary edema and respiratory distress.

So the word lethal describes the intended endpoint.

It does not transform the procedure into an infallible machine.

This is precisely why Pike’s case is historically extraordinary.

The Death Penalty Information Center says it is not aware of another modern U.S. case in which a prisoner survived after execution drugs were actually administered in this manner.

Others survived abandoned execution attempts.

Willie Francis survived a malfunctioning electric chair in 1946.

Romell Broom survived an Ohio execution attempt after personnel failed for hours to establish usable IV access.

Carruthers survived because Tennessee stopped before injecting the drug.

Pike is different.

Tennessee reached the chemical phase.

Then the backup chemical phase.

And she remained alive.

That does not prove pentobarbital cannot kill.

Thousands of medical toxicology cases and completed executions make clear that overwhelming barbiturate exposure can suppress respiration fatally.

What Pike’s survival demonstrates is something more uncomfortable.

A dose can be lethal on paper while failing to become a lethal dose in the bloodstream.

And when that happens, the person may receive neither the rapid death the state intended nor the safety standards a normal patient would expect.

Pike ended up trapped between those two systems.

Too little effective drug delivery, apparently, to kill her immediately.

Enough exposure and procedural injury to leave her critically ill.

That is why the burning in her arm may ultimately become the most important detail of the entire night.

It was not merely a complaint of pain.

It may have been the warning that explained everything.

The chemical was flowing.

But perhaps it was flowing into the wrong place.

Tennessee continued.

The first administration failed.

The backup failed.

The protocol ended.

And Christa Pike was still breathing.

Now an independent investigator must determine whether the execution team missed that warning, whether the protocol gave them a meaningful way to recognize it, and whether Tennessee can ever credibly say the procedure is reliable again.

The mystery is therefore not really how a human body somehow defeated an unstoppable poison.

The emerging possibility is much simpler.

The poison may never have reached the body in the way Tennessee believed it had.

And that is the frightening truth behind the phrase “lethal injection.”

The drug can be lethal.

The procedure can still fail.